NO119363B - - Google Patents
Download PDFInfo
- Publication number
- NO119363B NO119363B NO170500A NO17050067A NO119363B NO 119363 B NO119363 B NO 119363B NO 170500 A NO170500 A NO 170500A NO 17050067 A NO17050067 A NO 17050067A NO 119363 B NO119363 B NO 119363B
- Authority
- NO
- Norway
- Prior art keywords
- culture medium
- sulphate
- added
- group
- culture
- Prior art date
Links
- 239000001963 growth medium Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 208000026935 allergic disease Diseases 0.000 claims description 5
- 208000006673 asthma Diseases 0.000 claims description 5
- 229960000846 camphor Drugs 0.000 claims description 5
- 201000001245 periodontitis Diseases 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 241000295644 Staphylococcaceae Species 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 230000000737 periodic effect Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 244000052616 bacterial pathogen Species 0.000 claims description 3
- 239000002207 metabolite Substances 0.000 claims description 2
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims 1
- 229960002685 biotin Drugs 0.000 claims 1
- 235000020958 biotin Nutrition 0.000 claims 1
- 239000011616 biotin Substances 0.000 claims 1
- KTVIXTQDYHMGHF-UHFFFAOYSA-L cobalt(2+) sulfate Chemical compound [Co+2].[O-]S([O-])(=O)=O KTVIXTQDYHMGHF-UHFFFAOYSA-L 0.000 claims 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims 1
- 239000011790 ferrous sulphate Substances 0.000 claims 1
- 235000003891 ferrous sulphate Nutrition 0.000 claims 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims 1
- 235000019341 magnesium sulphate Nutrition 0.000 claims 1
- 239000011702 manganese sulphate Substances 0.000 claims 1
- 235000007079 manganese sulphate Nutrition 0.000 claims 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims 1
- 229960003966 nicotinamide Drugs 0.000 claims 1
- 235000005152 nicotinamide Nutrition 0.000 claims 1
- 239000011570 nicotinamide Substances 0.000 claims 1
- 229940055726 pantothenic acid Drugs 0.000 claims 1
- 235000019161 pantothenic acid Nutrition 0.000 claims 1
- 239000011713 pantothenic acid Substances 0.000 claims 1
- 235000007715 potassium iodide Nutrition 0.000 claims 1
- 235000008160 pyridoxine Nutrition 0.000 claims 1
- 239000011677 pyridoxine Substances 0.000 claims 1
- 239000011684 sodium molybdate Substances 0.000 claims 1
- 235000015393 sodium molybdate Nutrition 0.000 claims 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims 1
- 229940011671 vitamin b6 Drugs 0.000 claims 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims 1
- 239000011686 zinc sulphate Substances 0.000 claims 1
- 235000009529 zinc sulphate Nutrition 0.000 claims 1
- 239000000047 product Substances 0.000 description 10
- 230000037358 bacterial metabolism Effects 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 230000000172 allergic effect Effects 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000036512 infertility Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000000043 antiallergic agent Substances 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02K—DYNAMO-ELECTRIC MACHINES
- H02K13/00—Structural associations of current collectors with motors or generators, e.g. brush mounting plates or connections to windings; Disposition of current collectors in motors or generators; Arrangements for improving commutation
- H02K13/02—Connections between slip-rings and windings
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02K—DYNAMO-ELECTRIC MACHINES
- H02K3/00—Details of windings
- H02K3/04—Windings characterised by the conductor shape, form or construction, e.g. with bar conductors
- H02K3/22—Windings characterised by the conductor shape, form or construction, e.g. with bar conductors consisting of hollow conductors
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02K—DYNAMO-ELECTRIC MACHINES
- H02K9/00—Arrangements for cooling or ventilating
Landscapes
- Engineering & Computer Science (AREA)
- Power Engineering (AREA)
- Motor Or Generator Cooling System (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1640366A CH464333A (de) | 1966-11-15 | 1966-11-15 | Turbogenerator mit flüssigkeitsgekühlter Erregerwicklung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO119363B true NO119363B (xx) | 1970-05-11 |
Family
ID=4417065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO170500A NO119363B (xx) | 1966-11-15 | 1967-11-13 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3493795A (xx) |
| JP (1) | JPS4919043B1 (xx) |
| AT (1) | AT276553B (xx) |
| CH (1) | CH464333A (xx) |
| DE (1) | DE1588980B2 (xx) |
| FR (1) | FR1547811A (xx) |
| GB (1) | GB1182009A (xx) |
| NO (1) | NO119363B (xx) |
| SE (1) | SE341216B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4350908A (en) * | 1980-12-04 | 1982-09-21 | Westinghouse Electric Corp. | Cooling system for rotor of a dynamoelectric machine |
| SE428076B (sv) * | 1981-10-15 | 1983-05-30 | Asea Ab | Rotor for en turbogenerator |
| DE3145804A1 (de) * | 1981-11-19 | 1983-05-26 | ASEA AB, 72183 Västeraas | "rotor fuer einen turbogenerator" |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3189769A (en) * | 1961-08-01 | 1965-06-15 | Gen Electric | Dynamoelectric machine rotor cooling |
| GB977070A (en) * | 1962-04-23 | 1964-12-02 | Gen Electric | Liquid-cooled rotor for a dynamo-electric machine |
| US3353043A (en) * | 1965-05-14 | 1967-11-14 | Gen Electric | Conductor cooling system for dynamoelectric machine rotor |
| US3393333A (en) * | 1965-10-06 | 1968-07-16 | Gen Electric | Generator cooling structure |
-
1966
- 1966-11-15 CH CH1640366A patent/CH464333A/de unknown
-
1967
- 1967-04-24 DE DE19671588980 patent/DE1588980B2/de active Pending
- 1967-06-26 AT AT593267A patent/AT276553B/de active
- 1967-11-06 US US680872A patent/US3493795A/en not_active Expired - Lifetime
- 1967-11-13 SE SE15552/67A patent/SE341216B/xx unknown
- 1967-11-13 NO NO170500A patent/NO119363B/no unknown
- 1967-11-13 FR FR127865A patent/FR1547811A/fr not_active Expired
- 1967-11-13 GB GB51576/67A patent/GB1182009A/en not_active Expired
- 1967-11-14 JP JP42072848A patent/JPS4919043B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE1588980B2 (de) | 1972-11-23 |
| JPS4919043B1 (xx) | 1974-05-15 |
| US3493795A (en) | 1970-02-03 |
| CH464333A (de) | 1968-10-31 |
| FR1547811A (fr) | 1968-11-29 |
| DE1588980A1 (de) | 1970-07-23 |
| AT276553B (de) | 1969-11-25 |
| GB1182009A (en) | 1970-02-25 |
| SE341216B (xx) | 1971-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Maegraith et al. | Suppression of malaria (P. berghei) by milk | |
| NO119363B (xx) | ||
| Fraser-Moodie | CE Wallis Lecture: Struggle against Infection | |
| US3567822A (en) | Substances imparting a non - specific immunity and stimulating the natural defenses of the system | |
| US2922746A (en) | Microbiological product and method of making the same | |
| Bancroft et al. | Claude Bernard's theory of narcosis | |
| Kreidler | Treatment of pneumococcal infections in rabbits with sulfanilamide | |
| DE1942833C3 (de) | Verfahren zur Erzeugung von L-Asparaginase, danach hergestellte L-Asparaginase und diese enthaltendes therapeutisches Mittel | |
| Fennel | Prophylactic inoculation against pneumonia: a brief history and the present status of the procedure | |
| US1990982A (en) | Biological medicament | |
| US3857935A (en) | Therapeutic agent derived from the bacterium achromobacter stenohalis for treatment of canine infectious hepatitis | |
| US3196077A (en) | Process for cultivating foot and mouth disease virus on adult pig skin epithelium | |
| Herter | On certain relations between bacterial activity in the intestine and the indican of the urine | |
| Berks et al. | Terramycin and Spironema duttoni infections | |
| Crew | The Aschheim-Zondek test in the puerperium | |
| Vaquero et al. | Tension pneumocephalus in brain abscess after simple puncture-drainage | |
| HEKI et al. | Experimental studies in the treatment of tetanus and on a case of tetanus treated with usnic acid | |
| Wilmers | Encephalo-meningitis due to pneumococcus type 1 | |
| SU663714A1 (ru) | Способ получени анатоксина | |
| Buchanan | Antisepsis and antiseptics | |
| DE1003917B (de) | Verfahren zur Herstellung eines durch bakterielle Zersetzung erzeugten Komplexkonzentrats zur Behandlung von allergischen Krankheiten im allgemeinen, Asthma und Rheumatismus | |
| Wyse et al. | Diet and metabolic alterations in paraplegia | |
| US1547369A (en) | Scarlet-fever toxin and antitoxin and process for producing the same | |
| US2009610A (en) | Meningococcus toxin | |
| DE521739C (de) | Verfahren zur Herstellung von Impfstoffen |